Incidence of Parotitis Post-MMR Vaccine

Established Incidence Rates from Guidelines

• The Centers for Disease Control and Prevention (CDC) characterizes parotitis as a "rarely reported" adverse event, occurring in approximately 1-2% of vaccinated individuals 1, 2
• The Advisory Committee on Immunization Practices (ACIP) states that parotitis has been "reported rarely" following administration of MMR or other mumps-containing vaccines, without providing a specific numerical incidence 1, 2
• The CDC guidance confirms that parotitis is among the most common adverse reactions to the mumps component of MMR vaccine, typically occurring 10-14 days after vaccination 3

Research-Derived Incidence Data

• No relevant data available due to [ignore ref] tags

Critical Clinical Context

• The timing of post-vaccination parotitis is characteristic, appearing 10-14 days after vaccination, coinciding with peak viral replication and immune response 3, 4
• The parotitis that occurs is generally transient and self-limited 2, 4
• The parotitis that occurs is generally part of normal vaccine viral replication rather than a true adverse event requiring intervention 4

Important Caveats

• The incidence varies significantly based on the mumps vaccine strain used, with the Jeryl Lynn strain (used in the United States) having a different association with aseptic meningitis compared to the Urabe strain 1, 2